The goal of this clinical trial is to learn whether immersive technology (virtual reality) headsets can reduce procedural pain and anxiety during diagnosis, intralesional and intramuscular injections, and wound/dressing care in pediatric patients 5 years of age and older and adult patients with cutaneous leishmaniasis receiving treatment at the MSF clinic in Peshawar, Khyber Pakhtunkhwa, Pakistan.
Pediatric cutaneous leishmaniasis patients
Receiving cutaneous leishmaniasis care (diagnosis, treatment, and/or wound/lesion management) at the MSF cutaneous leishmaniasis facility in Peshawar
Legal guardian not present to obtain consent
Child with a significant neurological condition, or major developmental disability
A history of severe motion sickness
A history of seizures cause by flashing light
Single group
Virtual Reality
BehavioralParticipants interact with virtual reality games designed for procedural distraction while receiving medical treatment. Following treatment completion, participants undergo brief surveys and a semi-structured interview.
Participant feasibility and acceptability regarding immersive technology
Qualitative evaluation of participant attitudes, perceptions, and user experience with immersive technology headsets collected via semi-structured focus group interviews. Feedback will be categorized into core thematic domains including ease of use, comfort, and willingness to use in future care.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
